These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3291334)

  • 1. Effect of cyclosporine on glucose metabolism in kidney transplant recipients.
    Nakai I; Omori Y; Aikawa I; Yasumura T; Suzuki S; Yoshimura N; Arakawa K; Matsui S; Oka T
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):969-78. PubMed ID: 3291334
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cyclosporine on glucose metabolism in kidney transplant recipients and rats.
    Yagisawa T; Takahashi K; Teraoka S; Toma H; Agishi T; Ota K
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1801-3. PubMed ID: 3079039
    [No Abstract]   [Full Text] [Related]  

  • 3. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract]   [Full Text] [Related]  

  • 4. Deterioration in glucose metabolism in pancreatic transplant recipients after conversion from azathioprine to cyclosporine.
    Gunnarsson R; Klintmalm G; Lundgren G; Tydén G; Wilczek H; Ostman J; Groth CG
    Transplant Proc; 1984 Jun; 16(3):709-12. PubMed ID: 6375038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of cyclosporine to azathroprine in renal transplant recipients.
    Bassiri A; Amiranssari B; Gol S
    Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic problems in recipients of liver transplants.
    Jindal RM; Sidner RA; Hughes D; Pescovitz MD; Leapman SB; Milgrom ML; Lumeng L; Filo RS
    Clin Transplant; 1996 Apr; 10(2):213-7. PubMed ID: 8664522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New-onset diabetes mellitus after solid organ transplantation.
    Bodziak KA; Hricik DE
    Transpl Int; 2009 May; 22(5):519-30. PubMed ID: 19040489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.
    Hoitsma AJ; Hilbrands LB
    Clin Transplant; 2006; 20(5):659-64. PubMed ID: 16968494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative effects of immunosuppressive therapy on glucose metabolism.
    Smith WG; Thomas S; Griffin PJ; Salaman JR
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1502-3. PubMed ID: 2652484
    [No Abstract]   [Full Text] [Related]  

  • 13. New-onset diabetes after kidney transplantation: risk factors.
    Rodrigo E; Fernández-Fresnedo G; Valero R; Ruiz JC; Piñera C; Palomar R; González-Cotorruelo J; Gómez-Alamillo C; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S291-5. PubMed ID: 17130277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant.
    Luzi L; Picena Sereni L; Battezzati A; Elli A; Soulillou JP; Cantarovich D
    Transplantation; 2003 Jun; 75(12):2018-23. PubMed ID: 12829904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant diabetes mellitus after kidney transplantation with different immunosuppressive agents.
    Romagnoli J; Citterio F; Violi P; Nanni G; Castagneto M
    Transplant Proc; 2004 Apr; 36(3):690-1. PubMed ID: 15110632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
    Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
    Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating mechanisms of post-transplant diabetes mellitus.
    van Hooff JP; Christiaans MH; van Duijnhoven EM
    Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi8-vi12. PubMed ID: 15575024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The incidence, clinical implications, and risk factors of diabetes mellitus].
    Secchi A
    G Ital Nefrol; 2003; 20 Suppl 25():S7-10. PubMed ID: 14523906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.